Quick Summary:
In the constantly evolving healthcare landscape, the global Cold, Cough, and Sore Throat Remedies market provides a myriad of opportunities set to take the industry by storm. Its current market value stands at US$7 billion and is anticipated to rise to US$9.7 billion by 2030. Key market segments, such as Syrups & Drops and Tablets & Capsules, are positioned for significant growth, offering a potent chance for businesses to capitalize on these lucrative sectors.
This report is indispensable for any business committed to making an impact in this market. It offers comprehensive insights into the American and Chinese market situations, both promising accelerated growth for the discerning investor. It also features an overview of prominent competitors, equipping you with essential context to assess and refine your business strategies. Additionally, subscribe for a year of complimentary updates, ensuring your understanding of the market remains fresh and relevant. Stay ahead of the curve, harnessing the potential of the Cold, Cough, and Sore Throat Remedies market.
Global Cold, Cough, And Sore Throat Remedies Market to Reach $9.7 Billion by 2030
The global market for Cold, Cough, And Sore Throat Remedies estimated at US$7 Billion in the year 2022, is projected to reach a revised size of US$9.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030. Syrups & Drops, one of the segments analyzed in the report, is projected to record 4.7% CAGR and reach US$3.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Tablets & Capsules segment is readjusted to a revised 5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 8.1% CAGR
The Cold, Cough, And Sore Throat Remedies market in the U.S. is estimated at US$1.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 8.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.7% and 3.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.Select Competitors (Total 243 Featured) -
- Blackmores Ltd.
- Boiron USA
- Dabur India Ltd.
- Dr. Willmar Schwabe GmbH & Co. KG
- Emami Ltd.
- Himalaya Global Holdings Ltd.
- Hylands
- Johnson & Johnson
- Procter & Gamble Company, The
- Tsumura & Co.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Cold, Cough, And Sore Throat Remedies?
What is the growth rate of the Global Market for Cold, Cough, And Sore Throat Remedies?
What is the forecasted size of the Global Market for Cold, Cough, And Sore Throat Remedies?
Who are the key companies in the Global Market for Cold, Cough, And Sore Throat Remedies?
| Report Attribute | Details |
|---|---|
| No. of Pages | 289 |
| Published | September 2023 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 5.7 Billion |
| Forecasted Market Value ( USD | $ 8.1 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Blackmores Ltd.
- Boiron USA
- Dabur India Ltd.
- Dr. Willmar Schwabe GmbH & Co. KG
- Emami Ltd.
- Himalaya Global Holdings Ltd.
- Hylands
- Johnson & Johnson
- Procter & Gamble Company, The
- Tsumura & Co.
